Clinical Laserthermia Correlations
| CLS-B Stock | SEK 3.72 0.18 4.62% |
The current 90-days correlation between Clinical Laserthermia and Karolinska Development AB is -0.12 (i.e., Good diversification). The correlation of Clinical Laserthermia is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Clinical Laserthermia Correlation With Market
Good diversification
The correlation between Clinical Laserthermia Systems and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Clinical Laserthermia Systems and DJI in the same portfolio, assuming nothing else is changed.
Clinical |
The ability to find closely correlated positions to Clinical Laserthermia could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clinical Laserthermia when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clinical Laserthermia - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clinical Laserthermia Systems to buy it.
Moving together with Clinical Stock
Moving against Clinical Stock
Related Correlations Analysis
| 0.08 | 0.75 | 0.56 | 0.62 | CANTA | ||
| 0.08 | 0.44 | 0.65 | 0.66 | EPIS-B | ||
| 0.75 | 0.44 | 0.79 | 0.83 | KDEV | ||
| 0.56 | 0.65 | 0.79 | 0.9 | ACARIX | ||
| 0.62 | 0.66 | 0.83 | 0.9 | ATORX | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Clinical Stock performing well and Clinical Laserthermia Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Clinical Laserthermia's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CANTA | 2.05 | (0.68) | 0.00 | 2.73 | 0.00 | 2.25 | 36.57 | |||
| EPIS-B | 3.17 | 0.24 | 0.01 | (0.10) | 3.67 | 8.33 | 34.97 | |||
| KDEV | 2.37 | (0.15) | 0.00 | 8.70 | 0.00 | 5.05 | 18.09 | |||
| ACARIX | 3.01 | (0.47) | 0.00 | (7.67) | 0.00 | 4.35 | 33.86 | |||
| ATORX | 12.76 | 0.85 | 0.03 | (0.17) | 18.26 | 24.31 | 287.77 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Clinical Laserthermia without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Clinical Laserthermia Corporate Management
Elected by the shareholders, the Clinical Laserthermia's board of directors comprises two types of representatives: Clinical Laserthermia inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Clinical. The board's role is to monitor Clinical Laserthermia's management team and ensure that shareholders' interests are well served. Clinical Laserthermia's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Clinical Laserthermia's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rolf Bornschein | Chief Officer | Profile | |
| Mats Ekelund | Chief Officer | Profile | |
| LarsErik Eriksson | CoFounder Director | Profile | |
| Stephan MSc | Head Devel | Profile | |
| Karin Peterson | Chief Officer | Profile | |
| Marie MSc | Quality Mang | Profile | |
| Dan Mogren | Chief Officer | Profile |